10 Headache Medicine, v.2, n.1, p. 10-12, jan./feb./mar. 2011
Cerebrovascular reactivity in migraineurs
Vasorreatividade cerebral em migranosos
ABSTRACTABSTRACT
ABSTRACTABSTRACT
ABSTRACT
Cerebrovascular reactivity (CR) assessed by transcranial
Doppler (TCD) has been evaluated among migraineurs with
conflicting results. We assessed the CR using the breath holding
index (BHI) among 228 migraineurs during ictal or interictal
phase and 56 controls. Migraineurs exhibited increased BHI
values in the interictal phase and reduced BHI in the ictal
phase when compared to controls.
KK
KK
K
eywords:eywords:
eywords:eywords:
eywords: Transcranial Doppler Ultrasonography; Migraine
disorders; Headache; Cerebrovascular circulation.
RESUMORESUMO
RESUMORESUMO
RESUMO
A vasorreatividade cerebral medida pelo Doppler transcra-
niano tem sido avaliada em pacientes com migrânea com
resultados conflitantes. Nós avaliamos a vasorreatividade
cerebral utilizando o índice de apnéia (IA) em 228 pacientes
com o diagnóstico de migrânea nas fases ictal e interictal e
56 controles. Os pacientes apresentaram valores do IA
aumentados durante a fase interrictal e reduzidos durante a
fase ictal quando comparados aos controles.
Descritores:Descritores:
Descritores:Descritores:
Descritores: Ultrassonografia Doppler transcraniana;
Migrânea; Cefaleia; Circulação cerebrovascular
ORIGINAL ARTICLEORIGINAL ARTICLE
ORIGINAL ARTICLEORIGINAL ARTICLE
ORIGINAL ARTICLE
Arthur de Carvalho Jatobá e Sousa
1
, Ciro Martins Gomes
2
, Rodolfo de Souza Coelho
3
, Ricardo Afonso Teixeira
1
1
Instituto do Cérebro de Brasília, Brasília, DF, Brazil;
2
Hospital Universitário de Brasília, Brasília, DF, Brazil
3
Hospital de Base do Distrito Federal, Brasília, DF, Brazil
Sousa AC, Gomes CM, Coelho RS, Teixeira RA
Cerebrovascular reactivity in migraineurs. Headache Medicine. 2011;2(1):10-12
neuronal and/or vascular dysfunction,
(1)
which may be
due to genetic mutations associated to ion-transporting
mechanisms.
(2)
Conflicting results about cerebrovascular reactivity
and cerebral blood flow velocities have been described
among migraineurs. A few studies have reported an
increased cerebrovascular reactivity (CR),
(3,4)
while others
a normal and even a reduced CR.
(5-8)
The diagnosis of migraine headaches can be usually
made on clinical grounds alone in most patients. However,
it would be interesting to find a complementary assessment
tool to support its diagnosis. Cerebrovascular reactivity
assessed by transcranial Doppler could be a noninvasive
and cost effective tool that could possibly help in the
differential diagnosis of primary headaches.
The aim of this study is to compare the CR among
patients with migraine and controls. Our hypothesis is that
migraineurs show different CR status when compared to
controls.
METHODS
Two hundred and twenty eight consecutive migraineurs
were included in the study under informed consent
conditions (mean age = 33.82 years; range = 13 - 67;
women= 189). One hundred and fifty nine patients were
evaluated in the interictal period: 71 suffering from
migraine with aura (MA) and 88 from migraine without
aura (MWA). In addition, we evaluated 69 patients during
headache attacks: 36 with MA, 33 with MWA. We
compared the results to a control group of 56 individuals
INTRODUCTION
Migraine is one of the most common types of primary
headaches in clinical practice, but its pathophysiology is
not completely elucidated. The mechanism of migraine
headaches appears to involve the activation of the
trigeminocervical pain system by stimuli elicited by
Headache Medicine, v.2, n.1, p. 10-12, jan./feb./mar. 2011 11
with no personal history of headache (mean age = 42.41
years; range = 15-75; 31 women). All patients were
recruited from the neurology clinic of Santa Luzia Hospi-
tal in the city of Brasília - Brazil, from February 2003 to
June 2005. None of the patients was using prophylactic
antimigraine medication. Neither patients nor controls had
any antecedent of major disease and no vascular risk
factors such as hypertension, diabetes, dyslipidemia,
smoking. Diagnosis of migraine was made according
to the 1988 international classification of headache
disorders - 1 (ICHD-I).
(9)
In 2004 a revised international
classification of headache disorders (ICHD-II) was
published.
(10)
Since we had already started recruiting
patients using the ICHD-1, we carried on our study using
this previous classification. The study was conducted with
full approval by the institutional review boards.
The transcranial Doppler (TCD) study was carried
out in a quiet room with the individuals in supine position,
always during the afternoon. The reactivity to hypercapnia
was measured by the breath holding index (BHI). The
index was obtained by dividing the percentage increase
in mean flow velocity occurring during breath-holding by
the time (30 seconds) subjects held their breath after a
period of three minutes of normal breathing. We
considered the peak maximum value of the velocity curve,
which usually occurs a few seconds after the release. This
method has been validated as effective as methods
requiring carbon dioxide inhalation or acetazolamide
administration. We used an EZ-Dop transcranial Doppler
instrument (DWL Elektronische Systeme GmbH), with a
2-MHZ transducer fitted on a headband. The mean of
right and left BHI values were calculated.
ANOVA test and Tukey post hoc pairwise comparisons
were applied for comparisons on continuous variables
among the groups. The level of significance was set at
0.05.
RESULTS
All patients were able to hold their breath during 30
seconds when submitted to the test. Mean values of BHI
for migraineurs and controls are given in Table 1.
We found an increased BHI among migraineurs in
the interictal phase when compared to the control group
(migraine-interictal = 1.35; range = 0.37-2.87; controls
= 1.04; range = 0.535-1.177; p-value<0.001). During
migraine attacks, a significant decrease in BHI was
observed when compared to controls (migraineurs-ictal
= 0.82; range = 0.18-1.505; controls = 1.04; range
= 0.535-1.177; p-value < 0.001).
The BHI mean values were similar when comparing
migraineurs with aura and without aura in the ictal phase
(MA-ictal = 0.87; range = 0.18-1.41; MWA-ictal = 0.78;
range = 0.305-1.505; p = 0.214) and interictal phase
(MA-interictal = 1.35; range = 0.37-2.87; MWA-interictal
= 1.36; range = 0.465-2.305; p-value = 0.778).
DISCUSSION
Headache is a usual patient complaint in almost every
medical specialty. The very common occurrence of this
symptom in our population can lead to an expressive
economic loss and can also limit patients in ordinary life
activities. In the United States migraine affects about 12%
of the population, being three times more prevalent in
women than men, negatively affecting daily functioning
of most patients.
(11)
In Brazil, the prevalence of migraine
is estimated to be about 15%, being 2.2 times more
prevalent in women.
(12)
The use of the ICHD criteria for migraine headaches
can be considered a reliable tool to its diagnosis in most
patients. A large population-based study showed that self-
reported migraine among women was confirmed in 87%
when applying the ICHD-II criteria for migraine or
probable migraine without aura.
(13)
Although most patients
can be diagnosed on clinical grounds using the ICHD-II
criteria, sometimes the correct diagnosis of migraine
represents a challenge for both clinical practice and clinical
research.
The transcranial Doppler has been evaluated by some
studies as a potential tool for this purpose. Studies that
measured CR in the interictal phase have yielded conflicting
results, which may be due to different study methodologies.
Silvestrini et al. reported similar BHI in controls and in
patients during headache free periods. In this study the
BHI was calculated using the mean cerebral blood flow
(CBF) 4 seconds after the release.
(14)
Another study found
an exaggerated interictal BHI in migraineurs without aura
compared with the control group.
(4)
This study considered
the maximum point of CBF to calculate CR, which was
the methodology used in our study.
CEREBROVASCULAR REACTIVITY IN MIGRAINEURS
12 Headache Medicine, v.2, n.1, p. 10-12, jan./feb./mar. 2011
Correspondence
DrDr
DrDr
Dr
. Ricardo A. Ricardo A
. Ricardo A. Ricardo A
. Ricardo A
. T. T
. T. T
. T
eixeiraeixeira
eixeiraeixeira
eixeira
Instituto do Cérebro de Brasília
SHLS 716 - Conjunto L - Centro Clínico Sul - Torre II
2
o
andar - Sala 211
70390-700 – Brasília, DF, Brazil
Tel. (61) 3346-5383 - Fax. (61) 3346-9102
ricardoateixeira@yahoo.com
Studies that used different stimuli (e.g.; CO2
inhalation, hyperventilation) reported normal
(5,6)
or
reduced
(7,8)
CR in the interictal period. Other studies using
methods such as Xenon blood flow studies, SPECT, PET,
and functional magnetic resonance also reported
discordant results. The different methods of CR
measurement is a major factor that limits comparison
between studies.
Migraineurs might have an increased CR during the
headache-free period due to alterations in their autonomic
tonus. These patients might have a state of vagal
hyperactivity during headache free periods leading to an
enhanced vasodilatatory response. Furthermore, it has been
reported that migraineurs present an enhanced secretion
and response to nitric oxid.
(15)
A previous comparison between tension-type
headache (TTH) and migraine using the transcranial
Doppler was performed by Rosengarten et al., measuring
the evoked flow velocity in the posterior cerebral artery
utilizing a visual stimulation paradigm.
(16)
This study
showed that TTH patients had similar flow velocity
response during the ictal and interictal periods, which
was also comparable to controls. The same evaluation
in migraineurs demonstrated that CR was reduced during
the ictal phase when compared to the interictal phase,
suggesting an impaired vasodilatation reserve during the
ictal phase.
Our study has several limitations. Individuals evaluated
in the ictal phase were not the same ones tested in the
interictal phase. We did not control for the presence of
carotid stenosis, which can influence the breath holding
index. However, the mean age of the migraineurs and
the control group was relatively low to be influenced by
this variable.
In addition, due to the wide BHI variability found
among migraineurs, it does not seem possible to set a
BHI cutoff value to define migraine using the transcranial-
Doppler. However, it is tempting to consider that a
significant CR variation between ictal and interictal phase
in a single patient could be an additional information to
the diagnosis of migraine. Further research evaluating CR
of the same patient during ictal and interictal phases of
migraine would be of great value.
REFERENCES
1. Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2010;
30(2):120-30.
2. Sanchez-Del-Rio M, Reuter U, Moskowitz MA. New insights into
migraine pathophysiology. Curr Opin Neurol. 2006;19(3):294-8.
3. Fiermonte G, Pierelli F, Pauri F, Cosentino FII, Soccorsi R,
Giacomini P. Cerebrovascular CO2 reactivity in migraine with
aura and without aura. A transcranial Doppler study. Acta Neurol
Scand. 1995;92(2):166-9.
4. Dora B, Balkan S. Exaggerated interictal cerebrovascular reactivity
but normal blood flow velocities in migraine without aura.
Cephalalgia. 2002;22(4):288-90.
5. Silvestrini M, Cupini LM, Troisi E, Matteis M, Bernardi G.
Estimation of cerebrovascular reactivity in migraine without aura.
Stroke. 1995;26(1):81-3.
6. Thomsen LL, Iversen HK, Olesen J. Increased cerebrovascular
pCO2 reactivity in migraine with aura - a transcranial Doppler
study during hyperventilation. Cephalalgia. 1995;15(3):211-5.
7. Anzola GP, Magoni M, Volta GD. Abnormal cerebrovascular
reactivity in headache free migraineurs - a transcranial Doppler
study. Cerebrovasc Dis. 1993;3:105-10.
8. Totaro R, Marini C, De Matteis G, Di Napoli M, Carolei A.
Cerebrovascular reactivity in migraine during headache-free
intervals. Cephalalgia. 1997;17(3):191-4.
9. Headache Classification Committee of the International
Headache Society. Classification and diagnostic criteria for
headache disorders, cranial neuralgias, and facial pain.
Cephalalgia. 1988;8(suppl 7):1-96.
10. The International Classification of Headache Disorders: 2nd
edition. Cephalalgia. 2004;24:9-160.
11. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart
WF; AMPP Advisory Group. Migraine prevalence, disease
burden, and the need for preventive therapy. Neurology.
2007;68(5):343-9.
12. Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC,
Souza JA, Zukermann E. A nationwide population-based study
of migraine in Brazil. Cephalalgia. 2009;29(6):642-9.
13. Schürks M, Buring JE, Kurth T. Agreement of self-reported migraine
with the ICHD-II criteria in the Women´s health study.
Cephalalgia. 2009;29(10):1086-1090.
14. Silvestrini M, Matteis M, Troisi E, Cupini LM, Bernardi G.
Cerebrovascular reactivity in migraine with and without aura .
Headache. 1996;36(1):37-40.
15. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial
supersensitivity to nitric oxide (nitroglycerin) in migraine
sufferers. Cephalalgia. 1993;13(6):395-9.
16. Rosengarten B, Sperner J, Görgen-Pauly U, Kaps M.
Cerebrovascular reactivity in adolescents with migraine and
tension-type headache during headache-free interval and attack.
Headache. 2003;43(5):458-63.
SOUSA AC, GOMES CM, COELHO RS, TEIXEIRA RA